Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 20 results found. Search for [ Divi's Labs ]

Results 1 to 20 of 20
BT Online
November 2, 2017
While the Sensex fell 0.08 percent or 27 points to 33,573 level, the Nifty fell 16.70 points or 0.16 percent to 10,423 level. The S&P BSE healthcare index rose 2.48 percent or 353.24 points at 14,611 level after other pharma stocks rose due to positive sentiment emanating from the Divi's Laboratories development.


Rajeev Dubey
Delhi, May 1, 2017
A group of inheritors takes charge with new ideas and new strategies


BT Online
New Delhi, March 22, 2017
The S&P BSE Sensex ended at 29,167.68, falling 317.77 points while the NSE Nifty ended at 9,030.45, down 91.05 points.


E Kumar Sharma
New Delhi, March 21, 2017
Shares of Divi's Laboratories hit a 52-week low of Rs 635 on Tuesday after the company informed BSE that USFDA had issued them an import alert on 20th March, for the products manufactured at their unit at Visakhapatnam, Andhra Pradesh.


BT Online
New Delhi, March 21, 2017
The Indian benchmark indices ended in red with Pharma stocks being the major laggards.


BT Online
December 26, 2016
While Sensex fell over 250 points or 1 percent to 25,791 points, Nifty fell over 1 per cent or 80 points to 7906 level. Nifty was trading at its seven month low, its lowest level since May 26, 2016.


BT Online
December 23, 2016
The Sensex which opened in the negative territory at 25959 level recovered ground and hit an intra-day high of 26,143 level and intra day low of 25,872 level.


P.B. Jayakumar, E. Kumar Sharma and Venkatesha Babu
June 17, 2015
Most of them started with very little capital and resources. And all of them persevered through the bad times of the industry.


E. Kumar Sharma
September 18, 2014
Not all Indian bulk drug makers are reeling before the Chinese onslaught. Some have honed their processes to become world leaders in niche areas.


PTI
New York, May 22, 2014
As many as nine Indian firms have made it to the Forbes Worlds 100 most innovative growth companies list, which has been topped by New Zealand software accounting firm Xero.


PTI
New Delhi, September 23, 2013
Sun TV promoters Kalanithi Maran and his wife Kavery were the top paid corporates in India in the last fiscal with a package of Rs 56.25 crore each among the listed companies, replacing Jindal Steel's Naveen Jindal from the pole position.


Tanvi Varma/Money Today
July 29, 2013
Include stocks in the sectors that might gain from the rupee's fall. These include pharmaceutical and information technology that earn a big part of their revenues in dollars.


L Kishore Babu
June 3, 2013
Although the industry had time until 2005 to conform to the new patent regime, we consciously avoided short-term temptations,  says L. Kishore Babu, CFO, Divi's Labs.


E. Kumar Sharma
March 25, 2013
K. Anji Reddy founded what is today one of India's biggest drug companies, but his larger contribution was his focus on research and development.


BT Online Bureau
New Delhi, September 24, 2012
The chairman and managing director of Jindal Steel and Power Ltd tops the executive pay charts for listed companies in the country with a package of Rs 73.42 crore for the last fiscal 2011-12, which grew by over Rs six crore from previous year.


Tanvi Varma/Money Today
August 27, 2012
Companies in automobile, metals, infrastructure, and real estate sectors remained under pressure in the first quarter. But private sector banks, and companies in IT, pharmaceutical and FMCG sectors put up a good show. 


Hemen Kapadia
May 24, 2010
The Nifty's slide is no reason to worry. In fact, it's time to scout for stocks that are bound to yield good returns in the medium term.


R. Sree Ram
January 22, 2009
Investing in select pharma stocks might be the shot in the arm that your portfolio needs in times of a slowdown. The general environment for the pharma industry, particularly for domestic companies, seems positive.


Dipen Sheth
January 21, 2009
Boards and top managements need to behave in a way that tells the shareholders: we are squeaky clean, good at our business and can negotiate hard, but we will not cross the line when it comes to following the law and fairness in our dealings, writes Dipen Sheth.


By Krishna Gopalan
August 16, 2007
As state capitals get crowded, businesses are scrambling for newer destinations within and outside their home states. Happily for India Inc., there are quite a few cities to choose from.


PAGES 1 OF 1